Where does Meditab Software, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Meditab Software, Inc. ranks #48,648 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Meditab Software, Inc. hold?

Meditab Software, Inc. holds 5 US utility patents granted between 2017 and 2020, spanning 5 technology areas.

What is Meditab Software, Inc.'s Innovation Score?

Meditab Software, Inc. has an Innovation Score of 25.7 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Meditab Software, Inc.'s patent grant rate increasing or decreasing?

Meditab Software, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Meditab Software, Inc.'s patents?

Meditab Software, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Meditab Software, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Meditab Software, Inc.

Q: What technology areas does Meditab Software, Inc. focus on?

Meditab Software, Inc.'s top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 3 patents, ranking #300 of 903 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Meditab ranks #48,648 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#48,648
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.7/100): 19.4
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48648 · US Corporation #48,648 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,648/49,997
PHOTO-FINISH Media Network…
CPC-NARROW A61J · 5 areas
INNOV-THIN 25.7/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Media Network Services AS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Meditab’s 25.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (24%) Velocity 0.0 pts (0%) Breadth 7.9 pts (31%) Claim depth 11.6 pts (45%)

Qualcomm Incorporated · highest

85
Meditab Software · this assignee

26
3D Lighting… · lowest

7

What this shows Meditab's Innovation Score is 25.7/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Meditab?

Each dot is one of Meditab’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Meditab’s own 19.4 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Meditab vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Meditab's grants concentrate

Meditab Software, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 60% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Meditab sits between Media Network Services AS and Meljac.

Media Network Ser…

5
Mediatechnologies

5
Medical Developme…

5
Medicaltek

5
Medskin Solutions…

5
MEG Group

5
Meld Manufacturing

5
Meljac

5
Meditab Software ◀

5

What this shows Meditab holds 5 patents at rank #48,586, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Meditab

By rank, the assignees closest to #48,586 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Meditab's primary technology class.

Meditab's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Meditab Software, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	60.0%
2018	1	20.0%
2020	1	20.0%

Which technologies does Meditab Software, Inc. patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

G07F - Coin-freed OR Like Apparatus 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Meditab Software, Inc.'s patent record in context - here's where to go next.

Meditab Software, Inc.'s lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 60% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #48,648 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Meditab Software, Inc. against Media Network Services AS, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.